In South-Eastern Europe, and Western and Central Europe, amphetamine-type stimulants (ATS) use and health harm remain mainly linked to amphetamine and are relatively low compared to other regions.Amphetamines are the third most common stimulant drugs group in Europe after cocaine and “ecstasy”.…
The “ecstasy” market remains concentrated in Europe (mainly Western and Central Europe)The use of “ecstasy” is relatively high in Western and Central Europe with nearly 4 million of people estimated to have used the substance in the past year in 2024. In contrast, the estimated number of users was…
Seizures of amphetamine-type substances (ATS) in Europe are rising, with methamphetamine increasingly overtaking amphetamine.Seizures of ATS have increased strongly in Europe over the last decade, with growth reported for methamphetamine, amphetamine, “ecstasy” and non-specified and other ATS (…
